Suppr超能文献

推动对话:管理式医疗药学30年学术研究

Advancing the conversation: 30 years of scholarship in managed care pharmacy.

作者信息

Happe Laura E

机构信息

Journal of Managed Care and Specialty Pharmacy, Alexandria, VA; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville.

出版信息

J Manag Care Spec Pharm. 2025 Jul;31(7):617-626. doi: 10.18553/jmcp.2025.31.7.617.

Abstract

This article commemorates the 30th anniversary of the (), reflecting on its evolution to a central voice in managed care pharmacy. Launched in 1995, has chronicled the profession's growth while shaping the national conversation around value, access, and outcomes. The journal's early content addressed educational gaps and shared practical insights from the field, developing over time to feature rigorous health economics and outcomes research studies. and its authors played a pivotal role in elevating real-world evidence, as well as guiding stakeholders through transformative policy shifts like Medicare Part D and the Inflation Reduction Act. Over the years, has delved into complex topics such as management of high-cost drugs, value assessment, equity, and access. Acknowledging its most influential contributors and publications, this article illustrates how has remained a dynamic forum for scholarly dialogue. With an enduring legacy of connecting researchers, practitioners, and policymakers, remains poised to guide managed care pharmacy through future challenges in pursuit of improved patient health through evidence-based decision-making.

摘要

本文纪念()创刊30周年,回顾其发展成为管理式医疗药学核心声音的历程。该期刊于1995年创刊,记录了该专业的发展,同时塑造了围绕价值、可及性和结果的全国性讨论。该期刊早期的内容涉及教育差距,并分享了该领域的实用见解,随着时间的推移,发展为以严谨的卫生经济学和结果研究为特色。该期刊及其作者在提升真实世界证据方面发挥了关键作用,并指导利益相关者应对诸如医疗保险D部分和《降低通胀法案》等变革性政策转变。多年来,该期刊深入探讨了高成本药物管理、价值评估、公平性和可及性等复杂话题。本文认可其最具影响力的贡献者和出版物,阐述了该期刊如何一直是学术对话的活跃平台。凭借连接研究人员、从业者和政策制定者的持久遗产,该期刊仍准备好引导管理式医疗药学应对未来挑战,通过基于证据的决策改善患者健康。

相似文献

1
Advancing the conversation: 30 years of scholarship in managed care pharmacy.
J Manag Care Spec Pharm. 2025 Jul;31(7):617-626. doi: 10.18553/jmcp.2025.31.7.617.
3
How to Implement Digital Clinical Consultations in UK Maternity Care: the ARM@DA Realist Review.
Health Soc Care Deliv Res. 2025 May 21:1-77. doi: 10.3310/WQFV7425.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.
J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17.
7
Interventions for interpersonal communication about end of life care between health practitioners and affected people.
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
9
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.

本文引用的文献

1
Pharmacoequity measurement framework: A tool to reduce health disparities.
J Manag Care Spec Pharm. 2025 Feb 1;31(2):214-224. doi: 10.18553/jmcp.2025.31.2.214.
2
Emerging trends in managed care pharmacy: A mixed-method study.
J Manag Care Spec Pharm. 2025 Feb;31(2-a Suppl):S2-S10. doi: 10.18553/jmcp.2025.31.2-a.s2.
3
Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period.
J Manag Care Spec Pharm. 2024 Dec;30(12):1355-1363. doi: 10.18553/jmcp.2024.30.12.1355.
4
The effectiveness and value of ensifentrine for the treatment of chronic obstructive pulmonary disease.
J Manag Care Spec Pharm. 2024 Nov;30(11):1338-1342. doi: 10.18553/jmcp.2024.30.11.1338.
5
The effectiveness and value of midomafetamine-assisted psychotherapy for posttraumatic stress disorder.
J Manag Care Spec Pharm. 2024 Oct;30(10):1191-1195. doi: 10.18553/jmcp.2024.30.10.1191.
6
Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025.
J Manag Care Spec Pharm. 2024 Nov;30(11):1203-1210. doi: 10.18553/jmcp.2024.24167. Epub 2024 Sep 19.
7
A primer on copay accumulators, copay maximizers, and alternative funding programs.
J Manag Care Spec Pharm. 2024 Aug;30(8):883-896. doi: 10.18553/jmcp.2024.30.8.883.
8
Understanding racial disparities in health care expenditures for cervical cancer.
J Manag Care Spec Pharm. 2024 Aug;30(8):873-881. doi: 10.18553/jmcp.2024.30.8.873.
9
Reducing disparities in medication use: Responding to managed care pharmacy's imperatives.
J Manag Care Spec Pharm. 2024 Jul;30(7):747-751. doi: 10.18553/jmcp.2024.30.7.747.
10
Racial and social inequities in medication use: A review of articles responding to the + 's Call to Action.
J Manag Care Spec Pharm. 2024 Jul;30(7):736-746. doi: 10.18553/jmcp.2024.30.7.736.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验